An agentic coding tool tasked with cloning and setting up a seemingly benign GitHub repository could execute a malicious ...
US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid Regenxbio said on Monday the U.S. FDA has indicated that existing data for its rare-disease gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results